STSS Stock Analysis: Buy, Sell, or Hold?
STSS - Sharps Technology Inc. Common Stock
$1.56
-0.02 (-1.27%)
▼
5d:
-14.75%
30d:
-9.83%
90d:
-29.73%
HOLD
MODERATE Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: Mar 26, 2026
0d
Smart Money Accumulation
STSS is down 10.7% this week, but smart money is accumulating calls. Top strike: $2.5 2026-05-15 with 48 OI. Call ratio: 100% View Scanner →
Strength: 10.0/10
Get Alerted When STSS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: STSS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: STSS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: STSS is currently trading at $1.56, which is considered oversold relative to its 30-day fair value range of $1.71 to $1.89.
Technical Outlook: Technically, STSS is in a strong downtrend. The price is currently testing key support at $1.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: STSS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.00 (+1310.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, STSS is in a strong downtrend. The price is currently testing key support at $1.55. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: STSS has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $22.00 (+1310.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$1.71 -
$1.89
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 1310.3% below Wall St target ($22.00)
- CAUTION: 5-day price weakness (-14.8%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$1.71 -
$1.89
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$1.56
Resistance Level
$2.02
Current Trend
Strong Downtrend
Technical data as of
Mar 30, 2026
Fundamental Context
Wall Street Target
$22.00
(+1310.3%)
Share & Embed Analysis
Last updated: March 31, 2026 3:07 AM ET
Data refreshes hourly during market hours. Next update: 4:07 AM
Data refreshes hourly during market hours. Next update: 4:07 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is STSS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Saba Capital Management,…
SELL
12182 shares
2026-01-16
Saba Capital Management,…
SELL
25000 shares
2026-01-15
Saba Capital Management,…
SELL
77688 shares
2026-01-14
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 55 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 55 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 57 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 63 BUY |
|
AVTR
Avantor Inc |
HOLD
21 analysts |
$11 | 61 BUY |
